Day: March 31, 2026

us corporate news

Avenue Therapeutics Focuses on Neurologic Disease Therapies with ATX-04 and IV Tramadol as Key Product Candidates in 2026

Minichart

March 31, 2026

Avenue Therapeutics, Inc. Releases 2025 Annual Report: Key H...

Continue Reading 0

us corporate news

Yale Transaction Finders, Inc. 2025 Annual Report: Business Strategy, Financial Statements, and Company Overview

Minichart

March 31, 2026

Yale Transaction Finders, Inc. Annual Report Analysis - Key ...

Continue Reading 0

us corporate news

Dragonfly Energy Holdings Corp. 2025 Annual Report (10-K): Financials, Risk Factors, and Nasdaq Listing Overview

Minichart

March 31, 2026

Dragonfly Energy Holdings Corp. 2025 Annual Report – Key Hig...

Continue Reading 0

us corporate news

Spark I Acquisition Corporation 2025 Annual Report: Business Strategy, Kneron LOI, and SPAC Investment Focus

Minichart

March 31, 2026

Spark I Acquisition Corporation Files Annual Report: Key Hig...

Continue Reading 0

us corporate news

Interpace Biosciences 2025 Annual Report: Molecular Diagnostics, Business Strategy, and Key Risks

Minichart

March 31, 2026

Interpace Biosciences 2025 Annual Report – Key Investor Insi...

Continue Reading 0

us corporate news

StableX Technologies 2025-2026: Strategic Shift to Stablecoin Infrastructure Tokens and Digital Asset Treasury Model (SBLX 10-K Summary)

Minichart

March 31, 2026

StableX Technologies, Inc. 2025 Annual Report: Key Highlight...

Continue Reading 0

us corporate news

Nuo Therapeutics, Inc. 2025 Annual Report: Aurix System, Financial Risks, and Market Strategy Overview

Minichart

March 31, 2026

Nuo Therapeutics, Inc. 2025 Annual Report: Key Financial and...

Continue Reading 0

us corporate news

PDS Biotechnology Corp 2025 Annual Report: Versamune® Immunotherapy Pipeline, Clinical Results, and Executive Leadership Overview

Minichart

March 31, 2026

PDS Biotechnology Corp 2025 Annual Report: Key Highlights an...

Continue Reading 0

us corporate news

Viking Energy Group Focuses on Clean Energy Patents and Carbon-Capture Technologies – Risks, Intellectual Property, and Future Operations 29 30 31 32 35 36 56

Minichart

March 31, 2026

Camber Energy Inc. Financial Report Analysis: 2025 Annual 10...

Continue Reading 0

us corporate news

Glucotrack, Inc. 2025 Annual Report – Implantable Continuous Blood Glucose Monitor Development, Regulatory Progress, and Risk Factors 66

Minichart

March 31, 2026

Glucotrack, Inc. (GCTK) 2025 Annual Report: Key Highlights f...

Continue Reading 0